Townson Sharon
SEC CIK 1855689 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | CSO | 73.8K | — | $423.9K | 11 | 2025-01-02 | 2026-07-06 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-07 16:41 | 2026-07-06 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | M - OptEx | $6.14 | +6,000 | 73.8K | +9% | +$36.8K |
| DMT | 2026-07-07 16:41 | 2026-07-06 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | S - Sale+OE | $23.31 | -6,000 | 67.8K | -8% | -$139.8K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | M - OptEx | $6.14 | +3,000 | 70.8K | +4% | +$18.4K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | S - Sale+OE | $20.00 | -3,000 | 67.8K | -4% | -$60.0K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | M - OptEx | $6.14 | +3,000 | 70.8K | +4% | +$18.4K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | S - Sale+OE | $19.00 | -3,000 | 67.8K | -4% | -$57.0K |
| DT | 2026-06-01 16:05 | 2026-05-29 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | M - OptEx | $6.14 | +6,000 | 73.8K | +9% | +$36.8K |
| DT | 2026-06-01 16:05 | 2026-05-29 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | S - Sale+OE | $19.87 | -6,000 | 67.8K | -8% | -$119.2K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | A - Grant | — | +35.0K | 71.0K | +97% | — |
| D | 2026-01-05 | 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | S - Sale | $15.17 | -3,155 | 67.8K | -4% | -$47.9K |
| D | 2025-01-06 | 2025-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | CSO | A - Grant | — | +36.0K | 36.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations